Batista Danilo Vitor Vilhena, Jatobá Adolfo, da Silva Alexandre Vaz, de Souza Ana Paula, Farias Caio Francisco Santana, Lopes Emilly Monteiro, Owatari Marco Shizuo, Ventura Arlene Sobrinho, Cardoso Claudia Andrea Lima, Fontes Silvia Terra, Yamamoto Fernando Yugo, Martins Maurício Laterça, Mouriño José Luiz Pedreira
Aquatic Organism Health Laboratory - AQUOS, Federal University of Santa Catarina, Florianópolis, SC, Brazil.
Aquaculture Laboratory - Laq, Federal Institute of Santa Catarina, Araquari, SC, Brazil.
J Fish Dis. 2025 Jul 31:e70032. doi: 10.1111/jfd.70032.
The purpose of this research was to assess the effectiveness of a combination of monoterpenes (thymol and carvacrol) in treating juvenile Nile tilapia (Oreochromis niloticus) infected with Edwardsiella tarda as a potential substitute for the antibiotic oxytetracycline. The study utilised different concentrations of the monoterpenes blend (MTs): 0.4, 0.6 and 0.8 g kg of feed. A negative control group received a diet without the additive, while a positive control group was given medicated feed containing oxytetracycline (OTC) (11.85 g kg) for a 10-day treatment period. Cumulative mortality (%), haematological and immunological parameters were assessed after the feed administration. The negative control group experienced a mortality rate of 53%, while fish treated with medicated feed had a significantly lower mortality rate of 3%. The addition of MTs at concentrations of 0.4 g kg (13% mortality), 0.6 g kg (8% mortality) and 0.8 g kg (0% mortality) also resulted in reduced mortality rates, with the highest concentration showing survival rates comparable to the oxytetracycline group. Following the 10-day treatment period, no mortality was observed in the treated groups, indicating the efficacy of MTs-supplemented feed in alleviating the clinical symptoms of Edwardsiellosis. The haematological parameters indicated that as the dosage of MTs increased, the mean corpuscular volume (MCV) decreased. The MCV was significantly lower in the 0.6 and 0.8 g kg treatments compared to the control. Mean corpuscular haemoglobin initially increased with the 0.4 g kg MTs treatment but then decreased with higher doses. The mean corpuscular haemoglobin concentration was higher in the treated groups compared to the control. Red blood cell levels were higher in the 0.8 g kg MTs treatment and lower in the 0.4 g kg treatment. Ht was higher in the control group and lower in the 0.4 g kg MTs treatment. Haemoglobin levels followed a similar trend, with higher values in the control group. The 0.8 g kg MTs treatment had the highest number of total leucocytes and lymphocytes. The control group had the highest number of neutrophils, while the 0.8 g kg MTs group had higher numbers of monocytes, eosinophils, basophils and thrombocytes. The negative control exhibited the lowest antimicrobial titre compared to the OTC and the various concentrations of MTs. The concentrations of MTs (0.4, 0.6 and 0.8 g kg) demonstrated similar average values and were more effective than the control and OTC. There was no significant difference in agglutinating titre among MTs, control and OTC. Thymol and carvacrol notably decreased the mortality of tilapia infected with E. tarda, with a dosage as high as 0.8 g kg showing equivalent effectiveness to oxytetracycline. Furthermore, they enhanced haematological and immunological parameters, indicating that MTs could be a promising alternative to antibiotic use.
本研究的目的是评估单萜类化合物(百里香酚和香芹酚)组合作为抗生素土霉素的潜在替代品,对感染迟缓爱德华氏菌的尼罗罗非鱼幼鱼的治疗效果。该研究使用了不同浓度的单萜类化合物混合物(MTs):每千克饲料0.4、0.6和0.8克。一个阴性对照组接受不含添加剂的饲料,而一个阳性对照组在为期10天的治疗期内给予含土霉素(OTC)(每千克11.85克)的药饵。投喂饲料后评估累积死亡率(%)、血液学和免疫学参数。阴性对照组的死亡率为53%,而用药饵处理的鱼死亡率显著较低,为3%。添加浓度为每千克0.4克(死亡率13%)、0.6克(死亡率8%)和0.8克(死亡率0%)的MTs也导致死亡率降低,最高浓度组的存活率与土霉素组相当。经过10天的治疗期后,各治疗组均未观察到死亡情况,表明添加MTs的饲料在缓解爱德华氏菌病临床症状方面具有疗效。血液学参数表明,随着MTs剂量的增加,平均红细胞体积(MCV)降低。与对照组相比,每千克0.6克和0.8克处理组的MCV显著较低。平均红细胞血红蛋白最初在每千克0.4克MTs处理时增加,但在更高剂量时降低。与对照组相比,各治疗组的平均红细胞血红蛋白浓度更高。每千克0.8克MTs处理组的红细胞水平较高,每千克0.4克处理组较低。血细胞比容在对照组较高,每千克0.4克MTs处理组较低。血红蛋白水平呈现类似趋势,对照组的值更高。每千克0.8克MTs处理组的总白细胞和淋巴细胞数量最多。对照组的中性粒细胞数量最多,而每千克0.8克MTs组的单核细胞、嗜酸性粒细胞、嗜碱性粒细胞和血小板数量较多。与OTC和不同浓度的MTs相比,阴性对照组的抗菌效价最低。MTs(每千克0.4、0.6和0.8克)的浓度显示出相似的平均值,且比对照组和OTC更有效。MTs、对照组和OTC之间的凝集效价没有显著差异。百里香酚和香芹酚显著降低了感染迟缓爱德华氏菌的罗非鱼的死亡率,每千克高达0.8克的剂量显示出与土霉素相当的效果。此外,它们还改善了血液学和免疫学参数,表明MTs可能是抗生素使用的一个有前景的替代物。